Related Experiment Video
Updated: May 1, 2026

Investigating the Protective Effects of Platycodin D on Non-Alcoholic Fatty Liver Disease in a Palmitic Acid-Induced In Vitro Model
Published on: December 2, 2022
Anti-lipotoxic alkaloids from the roots of Polyalthia cerasoides
Feifei Liu1, Xinyi Liu1, Yue Chen1
1Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou, 570200, China.
Abstract:
Driven by the ethnomedicinal use of Polyalthia cerasoides (Roxb.) Bedd. for liver disorders and the urgent need for novel therapies against metabolic dysfunction-associated steatotic liver disease (MASLD), a phytochemical study of its roots was undertaken. This investigation resulted in the identification of twenty-nine alkaloids, including five previously unreported, rare pyridocoumarin alkaloids (1-5) and an undescribed 8-oxoberberine alkaloid (11). The structures of undescribed compounds were established through extensive NMR and MS data analysis. Isolates were evaluated for their anti-lipotoxic effects and ability to ameliorate lipid accumulation in a palmitic acid (PA)-induced model of MASLD using hepatocytes. Several alkaloids, notably compounds 3 and 24 (a known bis-aporphine), demonstrated significant protective effects. They concomitantly mitigated lipid overload and PA-induced apoptosis, showcasing their multi-faceted hepatoprotective potential. Our findings substantiate the ethnopharmacological value of P. cerasoides and highlight its alkaloids, particularly 3 and 24, as valuable scaffolds for the discovery of anti-MASLD agents.
More Related Videos
09:03Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
Published on: January 26, 2024
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
Related Concept Videos
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Drugs that Destabilize Microtubules
Drugs that Stabilize Microtubules
Antidotes
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...